Relationship between short-acting β2-adrenergic agonist use and healthcare costs. [electronic resource]
- The American journal of managed care Jan 2011
- 19-27 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1936-2692
Adolescent Adrenal Cortex Hormones--economics Adrenergic beta-Agonists--economics Adult Asthma--drug therapy Child Cost Savings Cross-Sectional Studies Disease Management Female Health Care Costs Health Status Indicators Hospitalization--economics Humans Insurance Claim Review Male Middle Aged Multivariate Analysis Retrospective Studies Severity of Illness Index United States Young Adult